Terns Pharmaceuticals, Inc.
TERN
$2.90
-$0.12-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.67% | 0.67% | 3.48% | -1.62% | -6.44% |
| Total Depreciation and Amortization | -21.03% | 3.88% | -14.17% | 1.69% | 7.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.25% | -57.47% | 7.69% | 23.58% | 91.42% |
| Change in Net Operating Assets | -182.43% | 376.28% | -54.86% | 163.76% | -2,265.22% |
| Cash from Operations | -67.58% | 11.37% | -1.71% | 29.03% | -18.03% |
| Capital Expenditure | -- | -- | 100.00% | 55.17% | 34.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.08% | -397.16% | -24.77% | 425.84% | -83.02% |
| Cash from Investing | 102.08% | -397.16% | -24.75% | 427.59% | -83.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.01% | -99.62% | 40,844.11% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.08% | -317.33% | -- | -- | -- |
| Cash from Financing | -77.63% | -99.81% | 40,825.31% | -- | -- |
| Foreign Exchange rate Adjustments | 95.65% | -230.19% | 478.57% | 46.15% | -110.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.38% | -160.85% | 576.74% | 278.03% | -135.27% |